NIAID Banner Logo Image

Mycobacterium Citations List: March, 2019

Literature Citations

1. Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer. Almeida, D.V., T.F. Omansen, S.Y. Li, J. Lee, J.H. Grosset, P.J. Converse, and E.L. Nuermberger. Antimicrobial Agents and Chemotherapy, 2019. 63(3): e02171-02118. PMID[30559131]. PMCID[PMC6395894].
[PubMed]. TB_03_2019.

2. In Vitro Antimycobacterial, Apoptosis-inducing Potential, and Immunomodulatory Activity of Some Rubiaceae Species. Aro, A.O., J.P. Dzoyem, A. Goddard, P. Fonteh, P.N. Kayoka-Kabongo, and L.J. McGaw. Frontiers in Pharmacology, 2019. 10: p. 185. PMID[30890938]. PMCID[PMC6413436].
[PubMed]. TB_03_2019.

3. The Diversified O-superfamily in Californiconus californicus Presents a Conotoxin with Antimycobacterial Activity. Bernaldez-Sarabia, J., A. Figueroa-Montiel, S. Duenas, K. Cervantes-Luevano, J.A. Beltran, E. Ortiz, S. Jimenez, L.D. Possani, J.F. Paniagua-Solis, J. Gonzalez-Canudas, and A. Licea-Navarro. Toxins, 2019. 11(2): E128. PMID[30791616]. PMCID[PMC6410186].
[PubMed]. TB_03_2019.

4. Modulatory Effects of Verapamil in Rifampicin Activity against Mycobacterium tuberculosis. Caleffi-Ferracioli, K.R., R.F. Cardoso, J.V. de Souza, L.S. Murase, P.H. Canezin, R.B. Scodro, V. Ld Siqueira, and F.R. Pavan. Future Microbiology, 2019. 14: p. 185-194. PMID[30648892].
[PubMed]. TB_03_2019.

5. Design and Synthesis of Novel Heterofused Pyrimidine Analogues as Effective Antimicrobial Agents. Chandrasekaran, B., S. Cherukupalli, S. Karunanidhi, A. Kajee, R.R. Aleti, N. Sayyad, B. Kushwaha, S.R. Merugu, K.P. Mlisana, and R. Karpoormath. Journal of Molecular Structure, 2019. 1183: p. 246-255. ISI[000459865900028].
[WOS]. TB_03_2019.

6. In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex. Cheng, A., Y.T. Tsai, S.Y. Chang, H.Y. Sun, U.I. Wu, W.H. Sheng, Y.C. Chen, and S.C. Chang. Antimicrobial Agents and Chemotherapy, 2019. 63(4): e02234-02218. PMID[30670428].
[PubMed]. TB_03_2019.

7. Phosphonodiamidate Prodrugs of N-Alkoxy Analogs of a Fosmidomycin Surrogate as Antimalarial and Antitubercular Agents. Courtens, C., M. Risseeuw, G. Caljon, P. Cos, A. Martin, and S. Van Calenbergh. Bioorganic & Medicinal Chemistry Letters, 2019. 29(9): p. 1051-1053. PMID[30857749].
[PubMed]. TB_03_2019.

8. Antimycobacterial and Nitric oxide Production Inhibitory Activities of Triterpenes and Alkaloids from Psychotria nuda (Cham. & Schltdl.) Wawra. de Carvalho Junior, A.R., R. Oliveira Ferreira, M. de Souza Passos, S.I. da Silva Boeno, L.L. Gloria das Virgens, T.L.B. Ventura, S.D. Calixto, E. Lassounskaia, M.G. de Carvalho, R. Braz-Filho, and I.J. Curcino Vieira. Molecules, 2019. 24(6): E1026. PMID[30875889].
[PubMed]. TB_03_2019.

9. Dicationic Liquid Mediated Synthesis of Tetrazoloquinolinyl methoxy phenyl 4-thiazolidinones and Their Antibacterial and Antitubercular Evaluation. Deshmukh, A.R., S.T. Dhumal, L.U. Nawale, V.M. Khedkar, D. Sarkar, and R.A. Mane. Synthetic Communications, 2019. 49(4): p. 587-601. ISI[000459158800010].
[WOS]. TB_03_2019.

10. Identification of Compounds with pH-dependent Bactericidal Activity against Mycobacterium tuberculosis. Early, J., J. Ollinger, C. Darby, T. Alling, S. Mullen, A. Casey, B. Gold, J. Ochoada, T. Wiernicki, T. Masquelin, C. Nathan, P.A. Hipskind, and T. Parish. ACS Infectious Diseases, 2019. 5(2): p. 272-280. PMID[30501173]. PMCID[PMC6371205].
[PubMed]. TB_03_2019.

11. Exploiting the Furo[2,3-b]pyridine Core against Multidrug-resistant Mycobacterium tuberculosis. Fumagalli, F., S.M.G. de Melo, C.M. Ribeiro, M.C. Solcia, F.R. Pavan, and F. da Silva Emery. Bioorganic & Medicinal Chemistry Letters, 2019. 29(8): p. 974-977. PMID[30803803].
[PubMed]. TB_03_2019.

12. Benzofuran-isatin-imine Hybrids Tethered via Different Length Alkyl Linkers: Design, Synthesis and in Vitro Evaluation of Anti-tubercular and Anti-bacterial Activities as Well as Cytotoxicity. Gao, F., T. Wang, M. Gao, X. Zhang, Z. Liu, S. Zhao, Z. Lv, and J. Xiao. European Journal of Medicinal Chemistry, 2019. 165: p. 323-331. PMID[30690301].
[PubMed]. TB_03_2019.

13. Identification of Pyrazolo[1,5-a]pyridine-3-carboxamide Diaryl Derivatives as Drug Resistant Antituberculosis Agents. Hu, X., B. Wan, Y. Liu, J. Shen, S.G. Franzblau, T. Zhang, K. Ding, and X. Lu. ACS Medicinal Chemistry Letters, 2019. 10(3): p. 295-299. PMID[30891129]. PMCID[PMC6421536].
[PubMed]. TB_03_2019.

14. Design, Synthesis, Biological Evaluation and Computational Study of Novel Triazolo[4,3-a]pyrazin Analogues. Jethava, D.J., P.T. Acharya, M.S. Vasava, M.N. Bhoi, Z.A. Bhavsar, S.K. Rathwa, D.P. Rajani, and H.D. Patel. Journal of Molecular Structure, 2019. 1184: p. 168-192. ISI[000461047100020].
[WOS]. TB_03_2019.

15. In Vitro Activity of the New β-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with β-Lactams against Mycobacterium abscessus Complex Clinical Isolates. Kaushik, A., N.C. Ammerman, J. Lee, O. Martins, B.N. Kreiswirth, G. Lamichhane, N.M. Parrish, and E.L. Nuermberger. Antimicrobial Agents and Chemotherapy, 2019. 63(3): e02623-02618. PMID[30642943]. PMCID[PMC6395916].
[PubMed]. TB_03_2019.

16. Discovery and Evaluation of Novel Mycobacterium tuberculosis Ketol-acid Reductoisomerase Inhibitors as Therapeutic Drug Leads. Krishna, V.S., S. Zheng, E.M. Rekha, L.W. Guddat, and D. Sriram. Journal of Computer-Aided Molecular Design, 2019. 33(3): p. 357-366. PMID[30666485].
[PubMed]. TB_03_2019.

17. Novel N-acyl Homoserine Lactone-degrading Bacteria Isolated from Penicillin-contaminated Environments and Their Quorum-quenching Activities. Kusada, H., Y. Zhang, H. Tamaki, N. Kimura, and Y. Kamagata. Frontiers in Microbiology, 2019. 10: p. 455. PMID[30923518]. PMCID[PMC6426785].
[PubMed]. TB_03_2019.

18. Peptides and Polyketides Isolated from the Marine Sponge-derived Fungus Aspergillus terreus SCSIO 41008. Luo, X.W., Y. Lin, Y.J. Lu, X.F. Zhou, and Y.H. Liu. Chinese Journal of Natural Medicines, 2019. 17(2): p. 149-154. PMID[30797421].
[PubMed]. TB_03_2019.

19. Synthesis and Structure-Activity Relationship Studies of Benzo[b][1,4]oxazin-3(4H)-one Analogues as Inhibitors of Mycobacterial thymidylate Synthase X. Modranka, J., J. Li, A. Parchina, M. Vanmeert, S. Dumbre, M. Salman, H. Myllykallio, H.F. Becker, R. Vanhoutte, L. Margamuljana, H. Nguyen, R. Abu El-Asrar, J. Rozenski, P. Herdewijn, S. De Jonghe, and E. Lescrinier. ChemMedChem, 2019. 14(6): p. 645-662. PMID[30702807].
[PubMed]. TB_03_2019.

20. Synthesis and Antimycobacterial Activity of Purine Conjugates with (S)-Lysine and (S)-Ornithine. Musiyak, V.V., D.A. Gruzdev, M.A. Kravchenko, D.V. Vakhrusheva, G.L. Levit, V.P. Krasnov, and V.N. Charushin. Mendeleev Communications, 2019. 29(1): p. 11-13. ISI[000460711400002].
[WOS]. TB_03_2019.

21. Identification of New Benzamide Inhibitor against α-Subunit of Tryptophan Synthase from Mycobacterium tuberculosis through Structure-based Virtual Screening, Anti-tuberculosis Activity and Molecular Dynamics Simulations. Naz, S., U. Farooq, S. Ali, R. Sarwar, S. Khan, and R. Abagyan. Journal of Biomolecular Structure and Dynamics, 2019. 37(4): p. 1043-1053. PMID[29502488].
[PubMed]. TB_03_2019.

22. Benzothiazol Clubbed Imidazol-4-ones as Anti-fungal, Anti-tubercular and anti-HIV-1 Agents: Their Synthesis and Molecular Docking Study. Patel, N.B., A.R. Shaikh, V.M. Patel, E.E. Lara-Ramirez, and G. Rivera. Letters in Drug Design & Discovery, 2019. 16(4): p. 382-391. ISI[000460607700002].
[WOS]. TB_03_2019.

23. Studies of Antimicrobial Resistance in Rare Mycobacteria from a Nosocomial Environment. Pereira, S.G., S. Alarico, I. Tiago, D. Reis, D. Nunes-Costa, O. Cardoso, A. Maranha, and N. Empadinhas. BMC Microbiology, 2019. 19(1): p. 62. PMID[30890149]. PMCID[PMC6425705].
[PubMed]. TB_03_2019.

24. Synthesis, Bioactivity, and Enzymatic Modification of Antibacterial Thiotetromycin Derivatives. Rothe, M.L., J. Li, E. Garibay, B.S. Moore, and S.M.K. McKinnie. Organic and Biomolecular Chemistry, 2019. 17(13): p. 3416-3423. PMID[30869693]. PMCID[PMC6437001].
[PubMed]. TB_03_2019.

25. In Vitro Activity of Tedizolid against Mycobacterium tuberculosis. Ruiz, P., M. Causse, M. Vaquero, and M. Casal. Antimicrobial Agents and Chemotherapy, 2019. 63(4): e01939-01918. PMID[30670412].
[PubMed]. TB_03_2019.

26. Expansion of a Novel Lead Targeting M. tuberculosis DHFR as Antitubercular Agents. Sharma, K., O. Tanwar, G.S. Deora, S. Ali, M.M. Alam, M.S. Zaman, V.S. Krishna, D. Sriram, and M. Akhter. Bioorganic & Medicinal Chemistry, 2019. 27(7): p. 1421-1429. PMID[30827867].
[PubMed]. TB_03_2019.

27. Solid Phase Synthesis of New Thiazolidinedione-Pyrimidine Conjugates and Their Antibacterial Properties. Slachtova, V., L. Janovska, and L. Brulikova. Journal of Molecular Structure, 2019. 1183: p. 182-189. ISI[000459865900020].
[WOS]. TB_03_2019.

28. Synthesis and Antitubercular Activity of 1- and 3-Substituted Benzo[g]isoquinoline-5,10-diones. Smets, R.J., E. Torfs, F. Lemiere, P. Cos, D. Cappoen, and K. Abbaspour Tehrani. Organic & Biomolecular Chemistry, 2019. 17(11): p. 2923-2939. PMID[30801604].
[PubMed]. TB_03_2019.

29. 3,5-Dialkoxypyridine Analogues of Bedaquiline are Potent Antituberculosis Agents with Minimal Inhibition of the hERG Channel. Sutherland, H.S., A.S.T. Tong, P.J. Choi, A. Blaser, D. Conole, S.G. Franzblau, M.U. Lotlikar, C.B. Cooper, A.M. Upton, W.A. Denny, and B.D. Palmer. Bioorganic & Medicinal Chemistry, 2019. 27(7): p. 1292-1307. PMID[30803745].
[PubMed]. TB_03_2019.

30. Synthesis and Antitubercular Evaluation of Reduced Lipophilic Imidazo[1,2-a]pyridine-3-carboxamide Derivatives. Wang, H., A. Wang, J. Gu, L. Fu, K. Lv, C. Ma, Z. Tao, B. Wang, M. Liu, H. Guo, and Y. Lu. European Journal of Medicinal Chemistry, 2019. 165: p. 11-17. PMID[30654236].
[PubMed]. TB_03_2019.

31. Identification of Novel DHFR Inhibitors for Treatment of Tuberculosis by Combining Virtual Screening with in Vitro Activity Assay. Wang, N., J.X. Ren, and Y. Xie. Journal of Biomolecular Structure and Dynamics, 2019. 37(4): p. 1054-1061. PMID[29504455].
[PubMed]. TB_03_2019.

Patent Citations

32. Preparation of Indoles for the Treatment of Bacterial Infections Such as Tuberculosis.Freundlich, J.S., D. Alland, M.B. Neiditch, D. Inoyama, G. Capodagli, and P. Kumar. Patent. 2019. 2018-US48607 2019046465: 92pp.
[Patent]. TB_03_2019.

33. Preparation of Indazoles for Treating Bacterial Infections Including Tuberculosis.Freundlich, J.S., D. Alland, M.B. Neiditch, P. Kumar, G. Capodagli, D. Awasthi, and S. Ekins. Patent. 2019. 2018-US48611 2019046467: 86pp.
[Patent]. TB_03_2019.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2019